Thyroid C-mobile Tumors: In rodent research, semaglutide is proven to result in thyroid C-mobile tumors. It truly is unidentified whether or not this threat relates to humans, but semaglutide is contraindicated in people with a private or spouse and children heritage of medullary thyroid carcinoma (MTC) or individuals with Multiple Endocrine Neopla